Purchase Order 75N92026P00028
- Not listed
- This is a $24,000.00 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business located in Lake Forest, California. The contract is for the provision of a hematology panel, including sequencing somatic mutations in bone marrow samples, in order to provide guidance for the treatment and diagnosis of disease. This contract is not associated with a...
- This is a $24,000 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a small disadvantaged business located in Lake Forest, California. The contract is for specialized hematology panel testing and genomic sequencing services to analyze somatic mutations in bone marrow samples, in order to provide guidance for the treatment and diagnosis of disease....
- This is a $45,000.00 firm-fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Heart, Lung and Blood Institute (NHLBI) to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract is for the provision of a 177-gene Hematology Panel, in support of NHLBI's biomedical research efforts. The contract does not have a set-aside designation. Genomic Testing Cooperative, LCA has held...
- This is a firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract, valued at $19,500.00, requires the contractor to provide hematology panel testing services, specifically sequencing somatic mutations in bone marrow samples, in order to provide guidance for the treatment and diagnosis of...
- This is a $24,000.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business located in Lake Forest, California. The contract is for hematology panel services, specifically the sequencing of somatic mutations in bone marrow samples to provide guidance in the treatment and diagnosis of disease. The contract has...
- This is a $85,500.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract is for providing next-generation genomic sequence test services to support biomedical research efforts, with a focus on hematology-related research. The contract does not have a set-aside designation and is scheduled...
- The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) awarded a firm-fixed-price purchase order contract to Genomic Testing Cooperative, LCA (GTC), a self-certified small disadvantaged business, for the provision of a 177-gene Hematology Panel. The $90,000.00 contract has an ultimate completion date of December 8, 2025 and supports the NHLBI's biomedical research initiatives, contributing to advancements in the understanding and treatment of various...
- This is a $24,000.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a small disadvantaged business. The contract is for providing a hematology panel to perform sequencing of somatic mutations in bone marrow samples, which will provide guidance in the treatment and diagnosis of disease. The contract has an ultimate completion date of December 30,...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business, for $114,000 to provide next generation sequencing on 177 genes. The contract has a completion date of November 1, 2023. Genomic Testing Cooperative is a tumor profiling laboratory that offers DNA and RNA testing for cancer biomarkers and has previously...
- The National Heart, Lung and Blood Institute of the National Institutes of Health, within the Department of Health and Human Services, awarded a $90,000 firm fixed price purchase order to Genomic Testing Cooperative LCA Genomic Testing Cooperative Division. The prime contractor will provide detection of somatic gene mutations in patients to the agency over a one year period of performance in Bethesda, Maryland. This contract has a total small business set aside designation. The award supports...
The National Heart, Lung and Blood Institute awarded a $24,000 purchase order contract to Genomic Testing Cooperative, LCA, a small disadvantaged business located in Lake Forest, California, for hematology panel sequencing and somatic mutation analysis services. The contract, which commenced on December 22, 2025 and extends through December 21, 2026, requires the contractor to conduct next-generation sequencing of bone marrow samples to identify somatic mutations that will provide guidance for disease diagnosis and treatment protocols. This firm fixed-price contract was awarded without a set-aside designation and represents the type of specialized genomic diagnostic work that NHLBI regularly procures to support its research and clinical initiatives in hematological disease understanding. Genomic Testing Cooperative, LCA has established a track record of delivering high-precision genomic testing services exclusively to NHLBI through multiple purchase order contracts, with individual awards ranging from $15,000 to $114,000. The company's core competency involves comprehensive gene panel sequencing—typically 177-gene panels—designed to detect mutations critical for understanding blood disorders and informing clinical decision-making. As a small disadvantaged business contractor based in California, the firm supports NHLBI's mission to advance understanding of diseases of the heart, lung, blood, and sleep through specialized molecular diagnostic capabilities that enable precision medicine approaches in federal research settings.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.0k | 12/18/25 |